Nuclear Medicine
Director – Molecular Imaging and Nuclear Medicine35 Years of Experience in Nuclear Medicine and Molecular Imaging
HCG Cancer Hospital, K R Road
Bangalore
Dr. Kumarswamy Gangadharayya Kallur is a senior Nuclear Medicine and Molecular Imaging specialist in Bengaluru with 35 years of experience. He currently serves as Director of Molecular Imaging and Nuclear Medicine at HCG Cancer Centre.
His key areas of expertise include general nuclear medicine, PET CT imaging, molecular imaging, theranostics, radionuclide imaging and radiopharmacy. He is involved in advanced cancer imaging for diagnosis, staging, treatment planning and response assessment.
Dr. Kumarswamy Gangadharayya Kallur completed his MBBS followed by Diploma in Radiation Medicine and MD in Radiation Oncology. His training background combines radiation oncology with advanced nuclear medicine practice.
His clinical interests include PET CT techniques such as FDG PET CT and PSMA PET CT, targeted radionuclide therapies and theranostic approaches for selected cancers including thyroid cancer, prostate cancer and neuroendocrine tumours.
Dr. Kallur has also played an important role in developing nuclear medicine infrastructure in India and has been associated with the Nuclear Medicine Department at HCG since its establishment in the 1990s.
PET CT combines functional nuclear imaging with CT imaging and is commonly used for cancer detection, staging, treatment planning and response assessment.
FDG PET CT uses a radioactive glucose tracer to identify areas of increased metabolic activity and is widely used in the evaluation of many cancers.
Ga-68 PSMA PET CT is an advanced molecular imaging technique commonly used for prostate cancer staging, recurrence assessment and treatment planning.
Molecular imaging provides functional information about biological processes within the body and supports accurate diagnosis and personalised treatment planning.
SPECT imaging uses gamma-emitting radiotracers to create three-dimensional functional images for selected nuclear medicine evaluations.
Theranostics combines targeted diagnostic imaging with radionuclide therapy, allowing the same molecular target to guide both diagnosis and treatment.
Radioiodine therapy uses radioactive iodine for the treatment of selected thyroid cancers and certain thyroid-related conditions.
Radionuclide therapy delivers targeted radiation through radiopharmaceuticals designed to accumulate in specific tumour tissues.
Nuclear medicine plays an important role in thyroid cancer diagnosis, follow-up and radioiodine-based treatment for selected patients.
PSMA-based PET CT imaging can help detect primary, recurrent and metastatic prostate cancer in appropriate clinical situations.
Theranostic nuclear medicine techniques can help identify receptor-positive neuroendocrine tumours and guide targeted radionuclide therapy.
Nuclear medicine imaging helps determine the extent and distribution of cancer and supports multidisciplinary treatment decisions.
PET CT and other molecular imaging techniques can help assess metabolic response to cancer treatment and monitor disease progression.
Radiopharmaceutical therapy uses radioactive compounds designed to target specific tissues or tumour cells while limiting radiation exposure to surrounding structures.
MBBS, DRM, MD (Radiation Oncology)
PET CT Scan, FDG PET CT, Ga-68 PSMA PET CT, SPECT Imaging, Molecular Imaging, Theranostics, Radioiodine Therapy, Radionuclide Therapy, Thyroid Cancer Imaging and Treatment, Prostate Cancer Imaging, Neuroendocrine Tumor Theranostics, Cancer Staging, Treatment Response Assessment, Radiopharmaceutical Therapy
Genuine patient experiences and treatment feedback.
Quick answers to common questions about Dr. Kumarswamy Gangadharayya Kallur
Yes. Radioiodine therapy for selected thyroid cancers is listed among his nuclear medicine treatment areas.
Yes. Theranostics is one of his main documented specialist interests, combining molecular imaging with targeted radionuclide therapy.
Yes. Ga-68 PSMA PET CT is documented among his advanced nuclear medicine and molecular imaging applications for prostate cancer.
Yes. PET CT imaging is one of Dr. Kumarswamy Gangadharayya Kallur's major documented areas of expertise.
His qualifications are MBBS, DRM and MD in Radiation Oncology.
Contact us for personalized help or to schedule an appointment.